Mojo, That is a question I have had for some time. Do we know how these events will be unblinded? Has Peregrine said how? Is it entirely up to Peregrine, or do FDA regulations dictate somehow the timing? The second-line NSCLC ORR data could be ready soon since the enrollment was completed on Oct 6, 2011. The trial regimen was for up to 6 cycles of 21 days, or 18 weeks, which means next week everyone on the trial will have been through all 6 cycles.